Geng Hongwu, Editor-in-Chief of China Medical Device Industry Development Blue Book, Confirmed Attendance at the 2020 Shaoxing Medical Device Industry Innovation and Development Conference
Geng Hongwu, Renowned Expert in Medical Device Policy and Editor-in-Chief of the Blue Book on China's Medical Device Industry DevelopmentConfirmed Attendance: Endogenous Power | 2020 Shaoxing Medical Device Industry Innovation and Development Conference.
October 12,Hosted by the People’s Government of Yuecheng District, the Talent Work Office of the Shaoxing Municipal Committee of the Communist Party of China, the Shaoxing Municipal Science and Technology Bureau, the Shaoxing Municipal Administration for Market Regulation, and the Shaoxing Association for Science and Technology; organized by the Talent Work Office of the Yuecheng District Committee of the Communist Party of China, the Yuecheng District Science and Technology Bureau, the Yuecheng District Administration for Market Regulation, the Yuecheng Association for Science and Technology, and the Shaoxing Yuecheng Medical Device Industry Innovation Service Complex;The Endogenous Power | 2020 Shaoxing Medical Device Industry Innovation and Development Conference, co-organized by Beijing Lanfeng Capital, Peking University Healthcare Innovation Valley, Shaoxing Lanbei Investment, VCBeat, and the Association for Science and Technology of the Shaoxing Yuecheng Medical Device Industry Innovation Service Complex Park, will be held at the Shaoxing Yuecheng Medical Device Industry Innovation Service Complex.。Conference Registration
Renowned Medical Device Expert, Editor-in-Chief of the Blue Book on the Development of China's Medical Device Industry.Executive Deputy Director of the Medical and Health Research Center, Tsinghua University Association of Senior Scientists and Engineers; Chief Marketing Advisor (former President of Business Operations) at Jointown Pharmaceutical Group; Founder of the China Pharmaceutical Procurement Alliance; Guest Lecturer for EMBA programs at Tsinghua University and Peking University; Lead Instructor for the continuing education course “Pharmaceutical Channel Management” at Peking University Health Science Center; Distinguished Expert appointed to the 2017 International Academic Committee of the Guangzhou International Rehabilitation Forum; Member of the Pharmacoeconomics Committee of the China Association of Traditional Chinese Medicine. Editor-in-Chief of the Chinese Academy of Social Sciences’ Blue Book Series on Medical Devices and Blood Transfusion Services. Author of the monographs Channel Management Made Simple and New E-commerce: Capturing the Remaining 3%. Editor-in-Chief of the four-volume Report on the Development of China’s Blood Transfusion Industry (2016–2019), the three-volume Report on the Development of China’s Medical Device Industry (2017–2019), and the single-volume Data Report on China’s Medical Device Industry (2019).
As a core resource on the supply side of the healthcare ecosystem, the medical device sector is reaping the dual benefits of domestic substitution and technological iteration. Bolstered by strong support from national policy directives, the medical device industry has entered a golden age of development.
Meanwhile, leveraging the dividends of foreign trade and innovation-driven economies, the Yangtze River Delta economic circle has consistently remained on a fast track for China’s economic growth. Shaoxing is part of the Hangzhou Metropolitan Area within the development plan for the Yangtze River Delta urban agglomeration and is also one of the key cities in the construction of Zhejiang Province’s Greater Bay Area. In 2019, Shaoxing was designated as a National Regional Innovation Center. Home to the Binhai New Area, one of Zhejiang Province’s four major strategic new areas, Shaoxing has received specialized policies and measures from the provincial government to comprehensively support the cultivation of an innovative cluster for the life and health industry, establish an integrated innovation service platform for the high-end medical device industry, and build a trillion-yuan health industry system encompassing services, manufacturing, and R&D.
Endogenous Power | Behind the Shaoxing Medical Device Industry Innovation and Development Conference lies Shaoxing’s pivotal role in building a future city for healthcare and constructing an innovative healthcare industry cluster. One of its key initiators, the Shaoxing Yuecheng Medical Device Industry Innovation Service Complex (hereinafter referred to as the “Yuecheng Complex”), serves as a representative model for Shaoxing’s innovation cluster development. Breaking away from the traditional operational model of physical agglomeration in industrial parks, the Yuecheng Complex has partnered with Peking University Healthcare Innovation Valley to provide service-centric, innovative park operations that facilitate the establishment of medical device companies. The Endogenous Power | Shaoxing Medical Device Industry Innovation and Development Conference not only reflects Shaoxing’s continuous advancement in building a future healthcare city but also demonstrates the Yuecheng Complex’s commitment to enhancing services and ecosystem development for settled enterprises.